As of 2025-05-31, the EV/EBITDA ratio of Natus Medical Inc (NTUS) is
18.83.
EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. NTUS's latest enterprise value
is 1,139.85 mil USD. NTUS's TTM EBITDA according to its financial statements is
60.53 mil USD. Dividing these 2
quantities gives us the above NTUS EV/EBITDA ratio.
|
Range |
Selected |
| Trailing P/E multiples |
15.2x - 18.0x |
16.8x |
| Forward P/E multiples |
18.3x - 28.4x |
24.6x |
| Fair Price |
15.79 - 31.54 |
25.40 |
| Upside |
-52.1% - -4.3% |
-22.9% |